Skip to content

PP&E (Net) at other companies

Eli Lilly logo
Eli LillyLLY
$26.54B+43.7%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$336.24M-6.8%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$142.4M+38.4%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$8.04M+323%
ALN
Alnylam PharmaceuticalsALNY
$518.26M+3.9%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$101.25M-7.6%

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+13.0%
Enterprise value$615.92M-22.3%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%
Debt / equity-0.1×
Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's PP&E (net)?
Wave Life Sciences (WVE) reported PP&E (net) of $7.08M in Q1 2026.
How has Wave Life Sciences's PP&E (net) changed year-over-year?
Wave Life Sciences's PP&E (net) decreased by 26.0% year-over-year, from $9.57M to $7.08M.
What is the long-term trend for Wave Life Sciences's PP&E (net)?
Over 5 years (2020 to 2025), Wave Life Sciences's PP&E (net) has grown at a -24.0% compound annual growth rate (CAGR), from $29.2M to $7.41M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.